Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Neurology | Family Medicine

Brain Cancer Clinical Trials

A listing of Brain Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arkansas

Little Rock : University of Arkansas for Medical Sciences

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

California

Duarte : City of Hope

A Phase II Clinical Trial Evaluating DCVax-Brain, Autologous Dendritic Cells Pulsed with Tumor Lysate Antigen for the Treatment of Glioblastoma Multiforme

Duarte : City of Hope

A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas

Duarte : City of Hope

An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma (The ACT IV Study)

Duarte : City of Hope

Phase I Study of Cellular Immunotherapy for Recurrent/Refractory Malignant Glioma Using Intratumoral Infusions of GRm13Z40-2, An Allogeneic CD8+ Cytolitic T-Cell Line Genetically Modified to Express the IL 13-Zetakine and HyTK and to be Resistant to Glucocorticoids, in Combination with Interleukin-2

Duarte : City of Hope

RTOG 0929: A Randomized Phase I/II Study of ABT-888 in Combination with Temozolomide in Recurrent (Temozolomide Resistant) Glioblastoma

Duarte : City of Hope

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Irvine : UCI Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

La Jolla : UCSD Moores Cancer Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Los Angeles : UCLA

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Newport Beach : Hoag Memorial Hospital Presbyterian

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Sacramento : Sutter Institute for Medical Research

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

San Francisco : University of California San Francisco

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

South Pasadena : South Pasadena Cancer Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Colorado

Aurora : University of Colorado Cancer Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

District of Columbia

Washington : Georgetown University Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Florida

Miami Beach : Mount Sinai CCOP

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Sarasota : Florida Cancer Specialists Updated

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma or Progressive Secondary Brain Tumor

Illinois

Elgin : Sherman Health

ECOG E3F05 Ph III RT + Temodar symptomatic/progress low grd glioma (astro, oligodendro, or oligastro) No pilocytic astro, gangioglioma, pleomorph xanthastro or dysembryoplastic neuorepithel. Supratentorial.

Chicago : Rush University Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Chicago : University of Illinois Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Peoria : Illinois Cancer Care

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Indiana

Indianapolis : IU Simon Cancer Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Massachusetts

Boston : Tufts Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Michigan

Ann Arbor : University of Michigan, Department of Neurosurgery

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Detroit : Henry Ford Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Minnesota

Minneapolis : Virginia Piper Cancer Institute

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Missouri

Kansas City : St. Luke's Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

St. Louis : Washington University School of Medicine

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

New Jersey

Basking Ridge : Memorial Sloan-Kettering at Basking Ridge

EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation

Basking Ridge : Memorial Sloan-Kettering at Basking Ridge

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Summit : Overlook Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Summit : Overlook Hospital

Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma

New York

Commack : Memorial Sloan-Kettering Cancer Center at Commack

EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation

Commack : Memorial Sloan-Kettering Cancer Center at Commack

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

Commack, Great Neck : Long Island Brain Tumor Centre at Neurological Surgery P.C.

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Huntington : Huntington Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Manhasset : North Shore University Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Mineola : Winthrop University Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

New York : Memorial Sloan Kettering Cancer Center

EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation

New York : Columbia University Medical Center

EGFR Inhibition Using High Dose Administration of Erlotinib Weekly for Recurrent Malignant Gliomas With EGFR Variant III Mutation

New York : Memorial Sloan Kettering Cancer Center

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

New York : Columbia University Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

New York : New York University Clinical Cancer Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

New York : New York University Clinical Cancer Center

Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma

Oceanside : South Nassau Community Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Rochester : University of Rochester Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Rockville Centre : Mercy Medical Center

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

White Plains : Brain and Spine Surgeons of New York and Northern Westchester Hospital

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

North Carolina

Chapel Hill : University of North Carolina

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

Durham : Duke University Medical Center

Aloxi for Prevention of Acute and Delayed Chemotherapy Induced Nausea and Vomiting (CINV) in Malignant Glioma (MG) Patients Receiving Irinotecan With Bevacizumab